FDA official says uniQure’s Huntington’s gene therapy trial lacked proof of slowing disease, calls for randomized placebo-controlled study.
Importance Rank:
1
FDA official says uniQure’s Huntington’s gene therapy trial lacked proof of slowing disease, calls for randomized placebo-controlled study.
The UCW Newswire : Financial, Business and Tech NewsCopyright © Louis Velazquez. All Rights Reserved.